MeSH D010698 - phobic disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001008:Anxiety disorders
D010698:
Phobic disorders
D000072861:Social phobia
0 Companies
0 Drugs
Success rate
D000092442:Kinesiophobia
0 Companies
0 Drugs
Success rate
D000379:Agoraphobia
D000098452:Claustrophobia
0 Companies
0 Drugs
Success rate
D000098453:School phobia
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Paroxetine | Paroxetine | 2007-06-29 | |||
| Mylan | Paroxetine hydrochloride, Paroxetine | Paroxetine | 2004-03-08 | |||
| Lupin Research | Paroxetine | Paroxetine | 2017-01-20 | |||
| Aurobindo Pharma | Paroxetine | Paroxetine | 2007-06-29 | |||
| Zydus Therapeutics | Paroxetine | Paroxetine | 2007-03-07 | |||
| Sun Pharmaceutical Industries | Paroxetine | Paroxetine | 2007-06-29 |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
33%3/9
Phase 3
50%3/6
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use